Back to today’s briefing

Story perspectives

Expert Highlights Breakthroughs in Urticaria Treatment and Research

1/25/2025

36 5

Summary

Story summary

Dr. Jason Hawkes, an Oregon dermatologist, shed light on the complexities of urticaria, distinguishing between chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CindU). He shared insights on innovative treatments like dupilumab and remibrutinib, while stressing the urgent need for improved diagnostics and research into biomarkers to enhance patient care and outcomes.

1 of 1

Story summary

Dr. Jason Hawkes, an Oregon dermatologist, shed light on the complexities of urticaria, distinguishing between chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CindU). He shared insights on innovative treatments like dupilumab and remibrutinib, while stressing the urgent need for improved diagnostics and research into biomarkers to enhance patient care and outcomes.